Demographics and clinical characteristics
Age | 63 ± 14 |
Male | 42 |
Race/ethnicity | |
African American | 268 (38) |
White | 215 (31) |
Latino | 164 (23) |
Health insurance | |
Private | 66 |
Medicare | 46 |
Medicaid | 18 |
Annual income ($) | |
<10,000 | 20 |
10–25,000 | 26 |
25–50,000 | 34 |
>50,000 | 21 |
Duration of diabetes | 9.9 ± 8.6 |
Self-reported comorbid conditions or complications | |
Hypertension | 74 |
Hypercholesterolemia | 65 |
Eye disease | 19 |
Kidney disease | 8 |
Foot disease (peripheral neuropathy and amputation) | 52 |
Heart disease | 30 |
Stroke | 11 |
Risk factor levels | |
A1C | 7.45 ± 1.62 |
A1C <7% | 47 |
LDL cholesterol (mg/dl) | 97 ± 34 |
LDL cholesterol <100 (mg/dl) | 61 |
Systolic blood pressure (mmHg) | 13 ± 18 |
Systolic blood pressure <130 mmHg | 42 |
Diastolic blood pressure (mmHg) | 74 ± 11 |
Diastolic blood pressure <80 mmHg | 65 |
Mean number of medications | 6 ± 4 |
Mean number of glucose-lowering medications | |
Chart report | 2 ± 1 |
Interview report | 1 ± 1 |
Mean number of diabetes-related medications (including blood pressure, cholesterol, and aspirin) | |
Chart report | 4 ± 2 |
Interview report | 4 ± 2 |
Glucose-lowering therapy | |
Diet alone | |
Chart report | 14 |
Interview report | 19 |
Oral medications alone | |
Chart report | 61 |
Interview report | 58 |
Insulin and oral medications | |
Chart report | 11 |
Interview report | 10 |
Insulin alone | |
Chart report | 14 |
Interview report | 13 |
Aspirin | |
Chart report | 38 |
Interview report | 40 |
Cholesterol-lowering drug | |
Chart report | 61 |
Interview report | 57 |
Blood pressure–lowering drug | |
Chart report | 77 |
Interview report | 73 |
Age | 63 ± 14 |
Male | 42 |
Race/ethnicity | |
African American | 268 (38) |
White | 215 (31) |
Latino | 164 (23) |
Health insurance | |
Private | 66 |
Medicare | 46 |
Medicaid | 18 |
Annual income ($) | |
<10,000 | 20 |
10–25,000 | 26 |
25–50,000 | 34 |
>50,000 | 21 |
Duration of diabetes | 9.9 ± 8.6 |
Self-reported comorbid conditions or complications | |
Hypertension | 74 |
Hypercholesterolemia | 65 |
Eye disease | 19 |
Kidney disease | 8 |
Foot disease (peripheral neuropathy and amputation) | 52 |
Heart disease | 30 |
Stroke | 11 |
Risk factor levels | |
A1C | 7.45 ± 1.62 |
A1C <7% | 47 |
LDL cholesterol (mg/dl) | 97 ± 34 |
LDL cholesterol <100 (mg/dl) | 61 |
Systolic blood pressure (mmHg) | 13 ± 18 |
Systolic blood pressure <130 mmHg | 42 |
Diastolic blood pressure (mmHg) | 74 ± 11 |
Diastolic blood pressure <80 mmHg | 65 |
Mean number of medications | 6 ± 4 |
Mean number of glucose-lowering medications | |
Chart report | 2 ± 1 |
Interview report | 1 ± 1 |
Mean number of diabetes-related medications (including blood pressure, cholesterol, and aspirin) | |
Chart report | 4 ± 2 |
Interview report | 4 ± 2 |
Glucose-lowering therapy | |
Diet alone | |
Chart report | 14 |
Interview report | 19 |
Oral medications alone | |
Chart report | 61 |
Interview report | 58 |
Insulin and oral medications | |
Chart report | 11 |
Interview report | 10 |
Insulin alone | |
Chart report | 14 |
Interview report | 13 |
Aspirin | |
Chart report | 38 |
Interview report | 40 |
Cholesterol-lowering drug | |
Chart report | 61 |
Interview report | 57 |
Blood pressure–lowering drug | |
Chart report | 77 |
Interview report | 73 |
Data are means ± SD, n (%), or %. n = 701.